RY 171.32 -0.1632% SHOP 146.83 -1.1179% TD 77.94 -1.1792% ENB 60.14 0.8384% BN 79.29 0.8394% TRI 224.35 -0.6422% CNQ 47.02 -0.318% CP 102.7 -0.993% CNR 149.12 -1.8947% BMO 130.825 0.3798% BNS 78.15 0.9299% CSU 4473.1602 0.5369% CM 89.8 0.0892% MFC 45.39 0.1324% ATD 77.605 -0.9635% NGT 60.16 1.3306% TRP 69.13 -1.144% SU 57.07 -0.2273% WCN 262.59 0.7482% L 175.29 -1.5114%
Company Overview: Full Circle Lithium Corp. (TSXV: FCLI) sounds like a key player in the growing field of sustainable battery material processing. As the demand for electric vehicles (EVs) and renewable energy storage solutions continues to rise, the need for efficient recycling of battery materials becomes increasingly critical. Cara Therapeutics Inc. (NASDAQ: CARA) is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
On November 07, 2024, the S&P 500 index settled at 5973.10 with a week till date gain of 4.56%; moreover, the tech-heavy NASDAQ composite advanced by ~5.64% on a WTD basis and settled at 19269.46. While, the Russell 2000 settled at 2382.69, reflecting a gain of ~7.81% on a WTD basis.
Considering the Canadian market, the benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week on a positive note and continued the momentum. On November 07, 2024, the index closed at 613.40 with an overall week-to-date (WTD) gain of 1.57%. Industrials, basic materials, technology, consumer cyclicals, energy, and were the leading sectors, while healthcare, real estate, and financials were the laggards on Thursday.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA 
AU
UK
US
NZ
Please wait processing your request...